We are proud to highlight the achievement of our talented undergraduate researcher, Muhammad Haris (BS Biotechnology), under the supervision of Dr. Farrukh Azeem (Associate Professor, Department of Bioinformatics and Biotechnology, Deputy Director Career Counseling and Alumni), who has developed HCMdrugs – a specialized database dedicated to Hypertrophic Cardiomyopathy (HCM), a life-threatening genetic heart disorder.

About HCMdrugs

HCMdrugs serves as a centralized drug database, compiling therapeutic agents, potential molecular targets, and worldwide drugs available for HCM under thousands of different brand names. This initiative is among the first of its kind in Pakistan, aiming to support researchers, clinicians, and students by providing accessible, disease-focused therapeutic information.

Future Vision: Towards AI-Powered Healthcare

ORIC is especially proud to see how this project connects with the future of AI-driven healthcare. Building on this foundation, Haris’ vision is to develop an AI-powered digital healthcare system that can:

• Integrate electronic health records (EHRs) and patient medical histories
• Assist doctors in personalized treatment planning
• Predict novel drug–target interactions for cardiac and genetic disorders
• Support early disease diagnosis through bioinformatics and machine learning tools
• Offer decision-support systems for clinicians and healthcare providers
• Provide patients with digital monitoring tools for long-term care and disease management

At ORIC-GCUF, we believe in nurturing young innovators who transform ideas into impactful solutions. HCMdrugs is a testament to how student research, guided by innovation and institutional support, can shape the future of medicine.

We congratulate Muhammad Haris on this remarkable step forward and reaffirm ORIC’s commitment to fostering cutting-edge research and commercialization potential at GCUF.